http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H1149659-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_20cf080a385f5a21756935fdd0152742 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-64 |
| filingDate | 1997-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34dc9a92056034ece3a43d45d30ebe88 |
| publicationDate | 1999-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H1149659-A |
| titleOfInvention | Skin application containing silk fibroin |
| abstract | PROBLEM TO BE SOLVED: To provide a skin coating composition which combines a wound healing promoting effect of silk protein and a recovery promoting effect of alginate, and has a great effect on prevention and recovery of rough skin. SOLUTION: For example, silk fibroin is added to 1000 ml of water in 0.1 ml. 050 g to 5 g, 0.050 g to 5 g of sodium alginate, Stir well. By the action of silk fibroin and sodium alginate (which may partially contain calcium), this solution gels and becomes a form suitable for application to the skin. By applying this, rough skin caused by long-term contact with water, detergent, or the like is promptly restored to fresh skin. In the case of work in a relatively short time, and in the case where application is allowed, by applying the skin application agent according to the present invention in advance before the work, skin roughness can be effectively prevented. . In actual use, it is desirable to add a preservative (for example, sodium benzoate of 30 mg or less) as appropriate. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004155679-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150088652-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008124975-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010513266-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6482420-B2 |
| priorityDate | 1997-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 64.